FrankABucciJr.MD

Ophthalmology • Wilkes-Barre, PA

Cataract Related

Physician

Join to view full profile

Are you Dr. Bucci?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 30 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
158 Wilkes Barre Township Blvd
Wilkes-Barre, PA 18702
Phone+1 570-825-5949

Fax+1 570-825-2645
Is this information wrong?

Summary

Dr. Frank Bucci Jr., MD is a board certified ophthalmologist in Wilkes-Barre, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Ohio, and Minnesota. He is affiliated with Wilkes-Barre General Hospital and Geisinger Wyoming Valley Medical Center.

Education & Training

University of MinnesotaResidency, Ophthalmology, 1989 - 1990
Albany Medical CenterResidency, Ophthalmology, 1986 - 1989
Jersey Shore University Medical CenterInternship, Transitional Year, 1985 - 1986
Rutgers New Jersey Medical SchoolClass of 1985

Certifications & Licensure

PA State Medical License 1992 - 2024
OH State Medical License 1990 - 1992
MN State Medical License 1989 - 1990
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects Start of enrollment: 2007 May 01
Completed
Phase 4
Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent? Start of enrollment: 2010 Oct 01
Completed
Phase 4
Evaluation the TECNIS IOL in Both Eyes VS the ReZoom IOL in One and TECNIS IOL in the Opposite Start of enrollment: 2010 Nov 01
Completed
Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification Start of enrollment: 2011 May 01
Completed
Phase 4
A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery Start of enrollment: 2011 May 01
Completed
Phase 4
Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery Start of enrollment: 2012 Jul 01
Terminated
Phase 3
Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra Start of enrollment: 2021 May 31
Withdrawn
Phase 4
Join now to see all

Publications & Presentations

PubMed

1 citations
Patient Satisfaction, Visual Outcomes, and Regression Analysis in Post-LASIK Patients Implanted With Multifocal, EDOF, or Monofocal IOLs.
Frank A Bucci Jr> ;Eye & Contact Lens. 2023 Apr 1
Accuracy and safety of partial thickness femtosecond laser radial and arcuate keratotomy incisions in porcine eyes.
E. Valas Teuma, Frank A. Bucci, Raman Bedi, Gary Gray, Mark Packer> ;Eye and Vision. 2021 Dec 1
3 citations
Multivariate Regression Analysis Identifying Predictors of Patient Satisfaction with Multifocal IOLs: +4.00/+4.00 vs +3.25/+3.25 vs +3.25/EDOF
Frank A. Bucci> ;Clinical Ophthalmology. 2020 Sep 28
19 citations
Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine ca...
Frank A. Bucci, Breanne Michalek, Angel T Fluet> ;Clinical Ophthalmology. 2017 Jun 1
70 citations
Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes.
Alice T Epitropoulos, Eric D. Donnenfeld, Zubin A. Shah, Edward J. Holland, Michael B. Gross, William J. Faulkner, Cynthia Matossian, Stephen S. Lane, Melissa M Toyos,...> ;Cornea. 2016 Sep 1
24 citations
Three-Year Longitudinal Survey Comparing Visual Satisfaction with LASIK and Contact Lenses
Marianne O. Price, David A. Price, Frank A. Bucci, Daniel S. Durrie, William I. Bond, Francis W. Price> ;Ophthalmology. 2016 Aug 1
9 citations
Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
Frank A. Bucci, Ines Teuma Nguimfack, Angel T Fluet> ;Clinical Ophthalmology. 2016 May 2
3 citations
Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
Frank A. Bucci, R.E. Evans, L.M. Amico, Timothy W. Morris, Angel T Fluet, Christine M Sanfilippo, Heleen H. DeCory, Timothy L. Comstock> ;Clinical Ophthalmology. 2015 May 13
29 citations
Prostaglandin E2 Inhibition of Ketorolac 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification
Frank A. Bucci, L. David Waterbury> ;Advances in Therapy. 2011 Nov 18
16 citations
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Frank A. Bucci, L. David Waterbury> ;Current Medical Research and Opinion. 2011 Nov 24
37 citations
Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery
Randall J. Olson, Eric D. Donnenfeld, Frank A. Bucci, Francis W Price, Michael B. Raizman, Kerry D Solomon, Uday Devgan, William Trattler, Steven J. Dell, R Bruce Wall...> ;Clinical Ophthalmology. 2010 Dec 10
15 citations
Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Frank A. Bucci, L. David Waterbury> ;Advances in Therapy. 2009 Jun 30
16 citations
Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Frank A. Bucci, L. David Waterbury> ;Journal of Cataract and Refractive Surgery. 2008 Sep 1
1 citations
Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
Frank A. Bucci, L. David Waterbury> ;Journal of Cataract and Refractive Surgery. 2008 Aug 1
16 citations
Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
Frank A. Bucci, L.M. Amico, R.E. Evans> ;Eye & Contact Lens. 2008 Jan 1
29 citations
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.
Frank A. Bucci, L. David Waterbury, L.M. Amico> ;American Journal of Ophthalmology. 2007 Jul 1
28 citations
An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
Frank A. Bucci> ;American Journal of Ophthalmology. 2004 Feb 1
4 citations
Mottled cyan opacification of the posterior cornea in contact lens wearers.
Frank A. Bucci, Jeffrey K. Harris, Edward J. Holland, Robert M. Lee, Donald J. Doughman, Jay H. Krachmer, Alvina M. Janda> ;American Journal of Ophthalmology. 1995 May 1
13 citations
Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole.
Frank A. Bucci, Edward J. Holland> ;American Journal of Ophthalmology. 1991 Jan 1
Join now to see all

Press Mentions

Volunteers Deliver Thanksgiving Dinner to Hospice PatientsNovember 28th, 2019
Hospice of the Sacred Heart Delivering Meals to PatientsNovember 22nd, 2018

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Hospital Affiliations

Wilkes-Barre General HospitalWilkes-Barre, Pennsylvania
Geisinger Wyoming Valley Medical CenterWilkes-Barre, Pennsylvania